Lon Cardon - 19 Dec 2022 Form 3 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Director
Signature
/s/ Jody Howe, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
19 Dec 2022
Net transactions value
$0
Form type
3
Filing time
19 Dec 2022, 20:22:00 UTC
Next filing
14 Jun 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.